Practical Radiation Oncology Publishes First IssueBy Elsevier, PRNE
Monday, January 24, 2011
NEW YORK, January 25, 2011 - Elsevier, a world-leading publisher of scientific, technical, and medical
information products and services, is pleased to announce the publication of
the first issue of Practical Radiation Oncology (
)(PRO) on behalf of the American Society for Radiation Oncology (ASTRO).
(Due to the length of this URL, it may be necessary to copy and paste
this hyperlink into your Internet browser's URL address field. Remove the
space if one exists.)
Under the guidance of Editor-in-Chief W. Robert Lee, MD, MS, MEd,
Practical Radiation Oncology aims to improve the quality of radiation
oncology practice. PRO will provide background for those in training and
continuing education for practitioners, through discussion and illustration
of new techniques and evaluation of current practices.
"Practical Radiation Oncology will serve as a worldwide forum for
radiation oncologists. I look forward with great enthusiasm to guiding PRO in
its mission of disseminating the most up-to-date information to its audience
and making it a must-read in the radiation oncology community," Dr. Lee
PRO will complement ASTRO's other official journal, the International
Journal of Radiation Oncology Biology Physics (the Red Journal). While
the Red Journal will continue to describe new discoveries in the field, PRO
will provide a context on such discoveries for its readers, and immediately
usable information. PRO will be distributed to ASTRO members as a benefit of
membership, along with the Red Journal.
"Elsevier is proud to continue its partnership with ASTRO in providing
invaluable information for the radiation oncology community," said Mary
Heffner, journal publisher. "We are impressed with the inaugural issue that
ASTRO has put together, and pleased to help disseminate this high-quality
content to its members and a global readership," she added.
All journal content, subscription information, and manuscript submission
links are available online at www.practicalradonc.org.
About the American Society for Radiation Oncology
ASTRO is the largest radiation oncology society in the world, with more
than 10,000 members who specialize in treating patients with radiation
therapies. As the leading organization in radiation oncology, biology and
physics, the Society is dedicated to improving patient care through
education, clinical practice, advancement of science and advocacy. For more
information on radiation therapy, visit www.rtanswers.org. To learn more
about ASTRO, visit www.astro.org.
Elsevier is a world-leading publisher of scientific, technical and
medical information products and services. The company works in partnership
with the global science and health communities to publish more than 2,000
journals, including The Lancet (www.thelancet.com/) and Cell (
www.cell.com/), and close to 20,000 book titles, including major
reference works from Mosby and Saunders. Elsevier's online solutions include
SciVerse ScienceDirect (www.sciencedirect.com/), SciVerse Scopus
(www.scopus.com/), Reaxys (https://www.reaxys.com/), MD Consult
(www.mdconsult.com/) and Nursing Consult (
www.nursingconsult.com/), which enhance the productivity of science
and health professionals, and the SciVal suite (www.scival.com/) and
MEDai's Pinpoint Review (www.medai.com/), which help research and
health care institutions deliver better outcomes more cost-effectively.
A global business headquartered in Amsterdam, Elsevier (
www.elsevier.com/) employs 7,000 people worldwide. The company is part
of Reed Elsevier Group PLC (www.reedelsevier.com/), a world-leading
publisher and information provider, which is jointly owned by Reed Elsevier
PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam),
REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).
Media Contact Rachael Zaleski +1-215-2393658 Rachael.firstname.lastname@example.org
Media Contact: Rachael Zaleski, +1-215-2393658, Rachael.zaleski at elsevier.com .
Tags: Elsevier, January 25, New York